NYSE:IQVLife Sciences
IQVIA (IQV): Assessing Valuation Following Global Clinical Partnership with Kexing Biopharm
IQVIA Holdings partners with Kexing Biopharm: What does it mean for investors?
IQVIA Holdings (NYSE:IQV) has announced a new partnership with Kexing Biopharm to accelerate the global development and commercialization of innovative drugs and biosimilars. The agreement leverages IQVIA’s strengths in clinical trial design, regulatory strategy, and operational scale, with the goal of expanding access to regulated markets in Europe and other regions. For those following the healthcare services...